Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

Result of AGM

23 Jun 2023 17:36

RNS Number : 8013D
Supply @ME Capital PLC
23 June 2023
 

23 June 2023

Supply@ME Capital plc

(the "Company" or "SYME")

Result of Annual General Meeting ("AGM")

 

SYME, the fintech business which provides an innovating platform ("Platform") for us by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow is pleased to announce that at the AGM held on 23 June 2023 all of the resolutions set out in the notice of AGM, dated 31 May 2023, were duly passed on a poll with the results as stated below.

Resolution

Type

In Favour

%

Against

%

Total

Withheld*

1. To receive the 2022 Annual Report and Accounts for the financial year ended 31 December 2022 together with the Directors' Report, Strategic Report and Auditors' Report on those accounts.

Ordinary

2,642,162,737

99.74

6,886,125

0.26

2,649,048,862

1,264,772

2. To approve the Directors' remuneration report for the financial year ended 31 December 2022.

Ordinary

2,629,954,150

99.31

18,232,816

0.69

2,648,186,966

2,126,668

3. To approve the Directors' Remuneration Policy.

Ordinary

2,628,985,769

99.28

19,034,860

0.72

2,648,020,629

2,293,005

4. To reconfirm and approve actions taken in 2022 and to date in 2023 consistent with the proposed Directors' Remuneration Policy, referred to in Resolution 3 above, in light of the prior year's Directors' Remuneration Policy including a typographical error.

Ordinary

2,633,932,715

99.48

13,849,400

0.52

2,647,782,115

2,531,519

5. To re-appoint Crowe U.K. LLP as auditors of the Company

Ordinary

2,641,443,097

99.69

8,113,340

0.31

2,649,556,437

757,197

6. To authorise the Directors to determine the amount of the Auditors' remuneration.

Ordinary

2,633,100,287

99.56

11,553,661

0.44

2,644,653,948

5,659,686

7. To re-appoint Mr. Albert Ganyushin as a Director.

Ordinary

2,638,575,917

99.63

9,680,504

0.37

2,648,256,421

2,057,213

8. To appoint Ms. Alexandra Galligan as a Director.

Ordinary

2,638,854,205

99.64

9,402,216

0.36

2,648,256,421

2,057,213

9. To authorise the Directors to: (i) allot shares or to grant rights to subscribe for or to convert any security into shares in relation to those warrants that have been issued to Venus Capital S.A., Mercator Capital Management Fund LP and Open Offer Warrantholders; and (ii) provide a further general authority. In total the authorities would permit the Directors to shares or to grant rights to subscribe for or to convert any security into shares representing 30% of the total number of issued Ordinary Shares as at the date of this Notice.

Ordinary

2,604,138,228

99.21

20,799,065

0.79

2,624,937,293

25,376,341

10.  To authorise the Directors to disapply pre-emption rights in respect of the authorities granted pursuant to Resolution 9.

Special

2,632,070,635

99.37

16,657,106

0.63

2,648,727,741

1,585,893

11.  To authorise the Company to call (other than an annual general meeting) on not less than 14 clear days' notice.

Special

2,639,480,715

99.67

8,851,249

0.33

2,648,331,964

1,981,670

*A vote withhold is not a vote in law and is not counted for the purposes of the calculation of the proportion of votes 'For' and 'Against' a resolution.

The results are also available on the Company's website by following the link below: https://www.supplymecapital.com/investor/shareholder-meetings/.

Contact information

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

MHP Group, SupplyME@mhpgroup.com

Notes

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global IM programme which will be focused on both inventory in transit monetisation and warehoused goods monetisation. This programme will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUOONROOUNUAR
Date   Source Headline
16th Jun 202610:08 amRNSAmendment to Nuburu On-Demand Funding Facility
11th Jun 202610:03 amRNSExercise of Open Offer Warrants
28th Apr 20267:00 amRNSExercise of Open Offer Warrants
27th Apr 20267:00 amRNSDelay in publishing 2025 Annual Financial Report
10th Apr 20267:00 amRNSExercise of Open Offer Warrants
16th Jan 20267:00 amRNSExercise of Open Offer Warrants
6th Jan 20267:00 amRNSProposed acquisition - Heads of Terms
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
5th Dec 202511:05 amRNSResults of AGM and Directorate Change
19th Nov 20257:00 amRNSBusiness update
6th Nov 20257:00 amRNSNotice of AGM
23rd Oct 20258:08 amRNSRestoration of Listing and Trading
23rd Oct 20257:30 amRNSRestoration - Supply@Me Capital plc
20th Oct 20257:00 amRNSFunding update
14th Oct 20257:00 amRNSH1 2025 unaudited interim report and accounts
13th Oct 20257:00 amRNS2024 Annual Report and Accounts
29th Sep 20257:00 amRNSDelay in publication of the H12025 interim results
18th Sep 20257:00 amRNSFunding update
15th Sep 20252:32 pmRNSFunding update
1st Sep 20257:00 amRNSFacility Amendment and Funding Update
31st Jul 20257:00 amRNSFunding update
16th Jul 20257:00 amRNSFunding update
2nd Jul 202512:00 pmRNSFunding update
24th Jun 20257:00 amRNSFunding update
11th Jun 20257:00 amRNSFacility Amendment and Funding Update
2nd Jun 20257:00 amRNSFunding Update
6th May 20257:00 amRNSPDMR Resignation
1st May 20257:00 amRNSFunding update
28th Apr 20257:00 amRNSDelay in published 2024 Annual Report and Accounts
1st Apr 202510:58 amRNSFunding update
19th Mar 20257:00 amRNSNew Funding Facility
14th Feb 20257:00 amRNSAppointment of new auditor
10th Feb 20257:00 amRNSFunding update
20th Jan 20257:00 amRNSDirector’s Other External Appointments
17th Dec 20247:00 amRNSBusiness Update
30th Sep 20242:45 pmRNSUnaudited interim results
25th Sep 20247:00 amRNSResignation of Auditor
6th Sep 20247:00 amRNSDirectorate Change
9th Jul 20247:00 amRNSExercise of Open Offer Warrants
28th Jun 20249:22 amRNSResult of AGM
31st May 202411:14 amRNSHolding(s) in Company
31st May 20247:00 amRNSTotal Voting Rights
29th May 20244:58 pmRNSNotice of Annual General Meeting
21st May 20247:00 amRNSStrategic alliance with p-Chip Corporation
15th May 20247:00 amRNSNew equity funding secured for £1,552,500
10th May 202411:47 amRNSPublication of the 2023 Annual Report and Accounts
9th May 20245:02 pmRNSIndependent Auditor's Report
1st May 20247:00 amRNS2023 Annual Report and Accounts
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.